Terms: = Prostate cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Treatment
3 results:
1. Survival Differences in High-Risk prostate cancer by Age.
García Fuentes C; Guijarro A; Hernández V; Gonzalo Á; Jiménez E; De la Peña E; Pérez E; Pérez E; Llorente C
Urol J; 2023 Jul; 20(4):215-221. PubMed ID: 36932725
[TBL] [Abstract] [Full Text] [Related]
2. Radiodynamic therapy using 15-MV radiation combined with 5-aminolevulinic acid and carbamide peroxide for prostate cancer in vivo.
Panetta JV; Cvetkovic D; Chen X; Chen L; Ma CC
Phys Med Biol; 2020 Aug; 65(16):165008. PubMed ID: 32464613
[TBL] [Abstract] [Full Text] [Related]
3. Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis.
Carneiro A; Baccaglini W; Glina FPA; Kayano PP; Nunes VM; Smaletz O; Bernardo WM; Carvalho IT; Lemos GC
Int Braz J Urol; 2017; 43(4):588-599. PubMed ID: 27802009
[TBL] [Abstract] [Full Text] [Related]
